Skip to main content
SpringerLink
Log in
Book cover

COPD pp 211–217Cite as

Prevention of COPD

  • Chapter
  • First Online:

  • 2750 Accesses

Abstract

Chronic obstructive pulmonary disease (COPD), a common preventable and treatable disease, is characterized by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and lungs to noxious particles or gases [1]. Chronic airway inflammation, which is a pathogenic mechanism of COPD, is caused by gene–environment interactions. Although the genetic factors contributing to gene–environment interactions cannot be controlled, COPD can be prevented if the environmental risk factors are eliminated. COPD prevention is more important than treatment because it is almost impossible to lung function normalization after airflow limitation occurs in COPD.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.

    Article  CAS  Google Scholar 

  2. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J. 2007;30(5):993–1013.

    Article  CAS  Google Scholar 

  3. Zeng G, Sun B, Zhong N. Non-smoking-related chronic obstructive pulmonary disease: a neglected entity? Respirology. 2012;17(6):908–12.

    Article  Google Scholar 

  4. Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC, Jonsson E, et al. Not 15 but 50% of smokers develop COPD?—report from the obstructive lung disease in northern Sweden studies. Respir Med. 2003;97(2):115–22.

    Article  CAS  Google Scholar 

  5. Tonnesen P. Smoking cessation and COPD. Eur Respir Rev. 2013;22(127):37–43.

    Article  Google Scholar 

  6. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD000146.

    PubMed  Google Scholar 

  7. Tashkin DP, Murray RP. Smoking cessation in chronic obstructive pulmonary disease. Respir Med. 2009;103(7):963–74.

    Article  Google Scholar 

  8. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2012;4:CD006103.

    Google Scholar 

  9. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007;1:CD000031.

    Google Scholar 

  10. McDonald CF, Khor Y. Advances in chronic obstructive pulmonary disease. Intern Med J. 2013;43(8):854–62.

    Article  CAS  Google Scholar 

  11. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ. 2008;336(7644):598–600.

    Article  Google Scholar 

  12. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733–43.

    Article  Google Scholar 

  13. Rojas-Martinez R, Perez-Padilla R, Olaiz-Fernandez G, Mendoza-Alvarado L, Moreno-Macias H, Fortoul T, et al. Lung function growth in children with long-term exposure to air pollutants in Mexico City. Am J Respir Crit Care Med. 2007;176(4):377–84.

    Article  CAS  Google Scholar 

  14. Gauderman WJ, Avol E, Gilliland F, Vora H, Thomas D, Berhane K, et al. The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med. 2004;351(11):1057–67.

    Article  CAS  Google Scholar 

  15. Laumbach RJ. Outdoor air pollutants and patient health. Am Fam Physician. 2010;81(2):175–80.

    PubMed  PubMed Central  Google Scholar 

  16. Fishwick D, Sen D, Barber C, Bradshaw L, Robinson E, Sumner J, et al. Occupational chronic obstructive pulmonary disease: a standard of care. Occup Med (Lond). 2015;65(4):270–82.

    Article  CAS  Google Scholar 

  17. Hanson C, Rutten EP, Wouters EF, Rennard S. Influence of diet and obesity on COPD development and outcomes. Int J Chron Obstruct Pulmon Dis. 2014;9:723–33.

    Article  Google Scholar 

  18. Duijts L, Reiss IK, Brusselle G, de Jongste JC. Early origins of chronic obstructive lung diseases across the life course. Eur J Epidemiol. 2014;29(12):871–85.

    Article  Google Scholar 

  19. Neuman A, Hohmann C, Orsini N, Pershagen G, Eller E, Kjaer HF, et al. Maternal smoking in pregnancy and asthma in preschool children: a pooled analysis of eight birth cohorts. Am J Respir Crit Care Med. 2012;186(10):1037–43.

    Article  Google Scholar 

  20. Stocks J, Sonnappa S. Early life influences on the development of chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2013;7(3):161–73.

    Article  Google Scholar 

  21. Jagana R, Bartter T, Joshi M. Delay in diagnosis of chronic obstructive pulmonary disease: reasons and solutions. Curr Opin Pulm Med. 2015;21(2):121–6.

    Article  Google Scholar 

  22. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994;272(19):1497–505.

    Article  CAS  Google Scholar 

  23. Bednarek M, Gorecka D, Wielgomas J, Czajkowska-Malinowska M, Regula J, Mieszko-Filipczyk G, et al. Smokers with airway obstruction are more likely to quit smoking. Thorax. 2006;61(10):869–73.

    Article  CAS  Google Scholar 

  24. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The lung health study. Am J Respir Crit Care Med. 2000;161(2 Pt 1):381–90.

    Article  CAS  Google Scholar 

  25. Stratelis G, Molstad S, Jakobsson P, Zetterstrom O. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care. 2006;24(3):133–9.

    Article  Google Scholar 

  26. Simmons MS, Connett JE, Nides MA, Lindgren PG, Kleerup EC, Murray RP, et al. Smoking reduction and the rate of decline in FEV(1): results from the lung health study. Eur Respir J. 2005;25(6):1011–7.

    Article  CAS  Google Scholar 

  27. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142(4):233–9.

    Article  Google Scholar 

  28. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009;374(9696):1171–8.

    Article  CAS  Google Scholar 

  29. Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178(4):332–8.

    Article  Google Scholar 

  30. Rennard SI, Drummond MB. Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet. 2015;385(9979):1778–88.

    Article  Google Scholar 

  31. Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;1:CD002733.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Yeouido St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea

    HyoungKyu Yoon

Authors
  1. HyoungKyu Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to HyoungKyu Yoon .

Editor information

Editors and Affiliations

  1. Department of Pulmonary and Critical, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea (Republic of)

    Sang-Do Lee

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yoon, H. (2017). Prevention of COPD. In: Lee, SD. (eds) COPD. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47178-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-47178-4_15

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-47177-7

  • Online ISBN: 978-3-662-47178-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation